8-K - Seres Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Management Change

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On February

Management Change

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 10.1 Letter Agreement dated March 2, 2026, by and between the Registrant and Kelly M. B

Exhibits Only

Exhibits (4)

10.1

EX-10.1

10.2

EX-10.2

10.3

EX-10.3

8-K